Use of extracorporeal blood purification therapy (ECBPT) as an adjuvant to high-dose corticosteroids in a severely ill COVID-19 patient with concomitant bacterial infection

COVID-19 presents with a spectrum of severity, ranging from asymptomatic or mild symptoms to those with acute respiratory distress syndrome. Corticosteroids are widely used for their efficacy in reducing inflammatory responses. However, its use may be limited to patients with immunosuppression. An a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Min Xian, Fong, Kean Khang, Yeap, Tat Boon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8515465/
https://www.ncbi.nlm.nih.gov/pubmed/34645636
http://dx.doi.org/10.1136/bcr-2021-245639

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8515465/
https://www.ncbi.nlm.nih.gov/pubmed/34645636
http://dx.doi.org/10.1136/bcr-2021-245639

Ejemplares similares